Publications


 

Conference proceedings

24. D Vlachakis, Kossida S. Introducing ADCD; the Antibody Drug Conjugate Designer suite. 7th Annual Proteins Congress; 2nd Annual Biosimilars & Biobetters Congress. London, UK, 3-4 April 2014

23. D Vlachakis, Tsiliki G, Kossida S. 3D Molecular Modelling of the Helicase Enzyme of the Endemic, Zoonotic Greek Goat Encephalitis Virus. 14th International Conference on Engineering Applications of Neural Networks, Halkidiki, Greece, 13-16 September 2013

22. Steinhauf D, Rodriguez A, D Vlachakis, Virgo G, Kristell C, Olsson I, Bongcam-Rudloff E, Kossida S, Bjerling P. Motifs in the Clr2 protein specific for mating-type silencing. Talk 73 & Poster 190. EMBO Conference on Fission Yeast: pombe 2013. 7th International Fission Yeast Meeting. London, United Kingdom, 24 - 29 June 2013

21. D Vlachakis, Koumandou VL, Kossida S. A holistic evolutionary and structural study of flaviviridae provides insights into the function and inhibition of HCV Helicase, 2013. EEBMB, 64th Conference in Athens.

20. D Vlachakis, Tsiliki G, Kossida S. 3D Molecular Modelling of the Helicase Enzyme of the Endemic, Zoonotic Greek Goat Encephalitis Virus, ISBN: 978-3-642-41012-3. 2013. Engineering Applications of Neural Networks, pp. 165-171.

19. D Vlachakis, Tsiliki G, Kondos D, Kontopoulos DG. Feidakis C, Kossida S. Applied bioinformatics in the structural, post-genomic era. COST Farm animal proteomics, ISBN: 978-90-8686-222-1. April 2013. pp 23-25.

18. D Vlachakis, Kossida S. Recipes to make the most out of your wetlab data in less than 10 minutes. AllBio Meeting. Milan, December 2012

17. D Vlachakis, M Vlassi. Molecular modelling of a novel series of Dengue virus (typeII) helicase potential inhibitors, by a de novo structure-based drug design approach. FEBS JOURNAL 276, 171-171, Prague, Czech-Republic, July 2009

16. Y Vangelatos, M Billini, D Vlachakis, V Sophianopoulou. Molecular modelling study of PrnB, the major proline transporter of Aspergillusnidulans. FEBS JOURNAL 276, 123-124, Prague, Czech-Republic, July 2009

15. Nikolopoulos G, D Vlachakis, Waltenspiel B, Warren W, Vlassi M. Preliminary structural characterization of DEFL, a good candidate for anticancer research. 33rd FEBS Congress, Molecular Machines, Athens, Greece, June-July 2008.

14. D Vlachakis, Sellis D, Tartas A, Nikolopoulos G, Economou I, Vlassi M. Evaluation of Molecular dynamics simulations using the known structural behaviour of a repeat containing protein. EEBE Conference, Thessaloniki, May 2008.

13. Brancale A, D Vlachakis, Kandil S, Biondaro S, Berry C, Neyts J. Discovery of a Novel HCV Helicase Inhibitor by a De Novo Drug Design Approach. Antiviral Research. 2008, 78(2):22. [doi:10.1016/j.antiviral.2008.01.030, ISSN: 0166-3542]

12. D Vlachakis, Tartas A, Vlassi M. Using molecular dynamics simulations to investigate the structural stability of a repeat containing protein. 32nd FEBS Congress, Molecular Machines, Vienna, Austria, July 2007

11. Nikolopoulos G, D Vlachakis, Waltenspiel B, Warren W, Vlassi M. Structure predictions, cloning and overexpression of DEFL, the product of a drosophila uncharacterized gene. 59th National Conference of the Hellenic Society of Biochemistry & Molecular Biology, Athens, December 2007.

10. Yalcintepe J, D Vlachakis, Prasse A, Müller-Quernheim J, Zissel G. Expression und Bedeutung des TLR9 auf BAL Zellen von PatientenmitSarkoidose und EAA. Pneumologie. 2007, 61(1):27. [doi:10.1055/s-2007-967248,ISSN:0934-8387]

09. Brancale A, D Vlachakis, Barbera MC, Silvestri R, Berry C, Netys J. Synthesis and evaluation of novel potential HCV Helicase inhibitors. Antiviral Research. 2006, 70(1):53. [doi:10.1016/j.antiviral.2006.02.001,ISSN:0166-3542]

08. Tartas A, D Vlachakis, Palaiomylitou M, Vlassi M. HelicosisMD: A Suite of computer programs for monitoring conformational changes during Molecular Dynamics simulations. 58th National Conference of the Hellenic Society of Biochemistry & Molecular Biology, Patras, November 2006.

07. D Vlachakis, Tartas A, Palaiomylitou M, Vlassi M. Using Molecular Dynamics Simulations to investigate the structural stability of the Tup1 Interaction Domain of the Transcriptional Regulator SSN6. 3rd Hellenic Crystallography Conference, Patras, October 2006.

06. Dragoumani K, D Vlachakis, Vlassi M. 3D–Modelling of the no-phosphorylating glyceraldehyde 3-Phasphate Dehydrogenase from S.Pyogenes. 3rd Hellenic Crystallography Conference, Patras, October 2006.

05. Meek KM, Knupp C, D Vlachakis, Boulton ME and Kamma CS. Homology-based molecular modelling of the bovine corneal biglycan core protein: implications for structure and function. Journal of Investigative Ophthalmology & Vision Sciences. 2006; 47(1):3000 [ISSN: 0146-0404]

04. D Vlachakis, Oldfield S and Brancale A. The three-dimensional structures of the Dengue virus, West Nile Virus, Japanese Encephalitis and Yellow Fever Polymerase proteins predicted by homology-based molecular modelling. Antiviral Research. 2005, 65(3):69. [doi:10.1016/j.antiviral.2005.01.001,ISSN: 0166-3542]

03. D Vlachakis, Berry C, Jones GW and Brancale A. An Assay for the biological testing of potential inhibitors for the HCV helicase, Dengue virus helicase and Dengue virus helicase/protease complex (NS3 domain). Antiviral Research. 2005, 65(3):60. [doi:10.1016/j.antiviral.2005.01.001,ISSN: 0166-3542]

02. D Vlachakis, Muller-Quernheim J, Zissel G. CXCR3 ligands and BAL cytology in ILD. EurRespir J. 2005; 26(49):101[ISSN: 0903-1936]

01. D Vlachakis, Muller-Quernheim J, Zissel G. CXCR3-Agonistic Chemokines in Interstitial Lung Diseases. 34thAnnual Meeting of the German Society of Immunology, Berlin, September 2003.


 
Top